rs771351747
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_000360.4(TH):āc.1400A>Gā(p.Asp467Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000552 in 1,540,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 33)
Exomes š: 0.000058 ( 0 hom. )
Consequence
TH
NM_000360.4 missense
NM_000360.4 missense
Scores
8
8
3
Clinical Significance
Conservation
PhyloP100: 4.94
Genes affected
TH (HGNC:11782): (tyrosine hydroxylase) The protein encoded by this gene is involved in the conversion of tyrosine to dopamine. It is the rate-limiting enzyme in the synthesis of catecholamines, hence plays a key role in the physiology of adrenergic neurons. Mutations in this gene have been associated with autosomal recessive Segawa syndrome. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.766
PP5
Variant 11-2164327-T-C is Pathogenic according to our data. Variant chr11-2164327-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 304067.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1, Pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TH | NM_000360.4 | c.1400A>G | p.Asp467Gly | missense_variant | 13/13 | ENST00000352909.8 | NP_000351.2 | |
TH | NM_199292.3 | c.1493A>G | p.Asp498Gly | missense_variant | 14/14 | NP_954986.2 | ||
TH | NM_199293.3 | c.1481A>G | p.Asp494Gly | missense_variant | 14/14 | NP_954987.2 | ||
TH | XM_011520335.3 | c.1412A>G | p.Asp471Gly | missense_variant | 13/13 | XP_011518637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TH | ENST00000352909.8 | c.1400A>G | p.Asp467Gly | missense_variant | 13/13 | 1 | NM_000360.4 | ENSP00000325951 | P1 | |
TH | ENST00000381178.5 | c.1493A>G | p.Asp498Gly | missense_variant | 14/14 | 1 | ENSP00000370571 | |||
TH | ENST00000381175.5 | c.1481A>G | p.Asp494Gly | missense_variant | 14/14 | 1 | ENSP00000370567 | |||
TH | ENST00000333684.9 | c.1118A>G | p.Asp373Gly | missense_variant | 11/11 | 1 | ENSP00000328814 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152112Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000553 AC: 11AN: 199036Hom.: 0 AF XY: 0.0000464 AC XY: 5AN XY: 107782
GnomAD3 exomes
AF:
AC:
11
AN:
199036
Hom.:
AF XY:
AC XY:
5
AN XY:
107782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000584 AC: 81AN: 1387894Hom.: 0 Cov.: 31 AF XY: 0.0000717 AC XY: 49AN XY: 683466
GnomAD4 exome
AF:
AC:
81
AN:
1387894
Hom.:
Cov.:
31
AF XY:
AC XY:
49
AN XY:
683466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152112Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74312
GnomAD4 genome
AF:
AC:
4
AN:
152112
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Autosomal recessive DOPA responsive dystonia Pathogenic:3Uncertain:1
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | May 12, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 498 of the TH protein (p.Asp498Gly). This variant is present in population databases (rs771351747, gnomAD 0.01%). This missense change has been observed in individual(s) with TH-related conditions and L-dopa responsive dystonia (PMID: 11160968, 15505183, 15747353). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 304067). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TH protein function. Experimental studies have shown that this missense change affects TH function (PMID: 24753243). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 24, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The TH c.1400A>G (p.Asp467Gly) missense variant has been reported in two studies in which it is found in a compound heterozygous state in three patients (including two brothers) with dopa-responsive dystonia (Furukawa et al. 2001; Schiller et al. 2004). The variant was found in a heterozygous state in two unaffected parents. The variant has also been reported in a heterozygous state in one patient with Parkinson disease (Rengmark et al. 2016). The p.Asp467Gly variant was absent from 230 controls and is reported at a frequency of 0.00014 in the European (non-Finnish) population of the Exome Aggregation Consortium. The Asp467 residue is conserved and located in the tetramerization domain suggesting that the variant may exert a significant influence on oligomerization of the protein. In a study in E. Coli, the presence of the p.Asp467Gly variant resulted in a significant reduction in protein levels with less than 10% residual activity compared to wild type protein (Fossbakk et al. 2014). Based on the evidence the p.Asp467Gly variant is classified as a variant of unknown significance but suspicious for pathogenicity for tyrosine hydroxylase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;.;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.;.;.
MutationTaster
Benign
D;D;D;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;D
REVEL
Pathogenic
Sift
Uncertain
D;D;.;D
Sift4G
Uncertain
D;D;D;D
Polyphen
P;P;.;P
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at